Spero Therapeutics Statistics
Total Valuation
SPRO has a market cap or net worth of $130.86 million. The enterprise value is $77.20 million.
Important Dates
The next estimated earnings date is Tuesday, August 11, 2026, after market close.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SPRO has 57.90 million shares outstanding. The number of shares has increased by 9.20% in one year.
| Current Share Class | 57.90M |
| Shares Outstanding | 57.90M |
| Shares Change (YoY) | +9.20% |
| Shares Change (QoQ) | -3.51% |
| Owned by Insiders (%) | 3.78% |
| Owned by Institutions (%) | 19.80% |
| Float | 46.52M |
Valuation Ratios
The trailing PE ratio is 8.67.
| PE Ratio | 8.67 |
| Forward PE | n/a |
| PS Ratio | 2.14 |
| Forward PS | n/a |
| PB Ratio | 2.47 |
| P/TBV Ratio | 2.47 |
| P/FCF Ratio | 18.07 |
| P/OCF Ratio | 18.07 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 5.07 |
| EV / Sales | 1.26 |
| EV / EBITDA | n/a |
| EV / EBIT | 5.45 |
| EV / FCF | 10.66 |
Financial Position
The company has a current ratio of 10.50, with a Debt / Equity ratio of 0.05.
| Current Ratio | 10.50 |
| Quick Ratio | 10.23 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.16 |
| Debt / FCF | 0.34 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 35.12% and return on invested capital (ROIC) is 133.19%.
| Return on Equity (ROE) | 35.12% |
| Return on Assets (ROA) | 12.96% |
| Return on Invested Capital (ROIC) | 133.19% |
| Return on Capital Employed (ROCE) | 26.48% |
| Weighted Average Cost of Capital (WACC) | 12.03% |
| Revenue Per Employee | $2.45M |
| Profits Per Employee | $609,400 |
| Employee Count | 25 |
| Asset Turnover | 0.89 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SPRO has paid $261,000 in taxes.
| Income Tax | 261,000 |
| Effective Tax Rate | 1.68% |
Stock Price Statistics
The stock price has decreased by -22.07% in the last 52 weeks. The beta is 1.46, so SPRO's price volatility has been higher than the market average.
| Beta (5Y) | 1.46 |
| 52-Week Price Change | -22.07% |
| 50-Day Moving Average | 2.62 |
| 200-Day Moving Average | 2.40 |
| Relative Strength Index (RSI) | 42.53 |
| Average Volume (20 Days) | 1,863,650 |
Short Selling Information
The latest short interest is 1.71 million, so 2.95% of the outstanding shares have been sold short.
| Short Interest | 1.71M |
| Short Previous Month | 1.65M |
| Short % of Shares Out | 2.95% |
| Short % of Float | 3.67% |
| Short Ratio (days to cover) | 2.32 |
Income Statement
In the last 12 months, SPRO had revenue of $61.19 million and earned $15.24 million in profits. Earnings per share was $0.26.
| Revenue | 61.19M |
| Gross Profit | 33.42M |
| Operating Income | 14.18M |
| Pretax Income | 15.50M |
| Net Income | 15.24M |
| EBITDA | n/a |
| EBIT | 14.18M |
| Earnings Per Share (EPS) | $0.26 |
Full Income StatementBalance Sheet
The company has $56.13 million in cash and $2.47 million in debt, giving a net cash position of $53.66 million or $0.93 per share.
| Cash & Cash Equivalents | 56.13M |
| Total Debt | 2.47M |
| Net Cash | 53.66M |
| Net Cash Per Share | $0.93 |
| Equity (Book Value) | 52.93M |
| Book Value Per Share | 0.91 |
| Working Capital | 52.12M |
Full Balance SheetCash Flow
| Operating Cash Flow | 7.24M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | 7.24M |
| FCF Per Share | $0.13 |
Full Cash Flow StatementMargins
Gross margin is 54.61%, with operating and profit margins of 23.17% and 24.90%.
| Gross Margin | 54.61% |
| Operating Margin | 23.17% |
| Pretax Margin | 25.33% |
| Profit Margin | 24.90% |
| EBITDA Margin | n/a |
| EBIT Margin | 23.17% |
| FCF Margin | 11.84% |